Pharma Pulse 5/28/24: Global Insulin Delivery Systems Strategic Research Report 2024, A Fun and Insightful Exploration of Behavioral Science & more

A Fun and Insightful Exploration of Behavioral Science

Sharing an entertaining dive into the origins, milestones, and future of behavioral economics—where lessons can be applied to clinical practice.

A Conversation Veteran Healthcare Lobbyist Paul Kelly | DC Roundtable

A limited pharmacy benefit manager (PBM) reform bill may be used as a "pay for" to offset the costs of extending Medicare telehealth flexibilities, shares Kelly, of Capitol Advocacy & Government Affairs.

Big Tech Moves More AI Spending Abroad

So far this year, Microsoft and Amazon have earmarked more than $40 billion combined for investments in AI-related and data center projects worldwide.

Global Insulin Delivery Systems Strategic Research Report 2024: Market to Reach $16.8 Billion by 2030

The "Insulin Delivery Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is projected to reach a revised size of US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030.

Stephanie Ramos (she/her) on LinkedIn:

#RFID supports a more efficient and accurate medication-use process that can enhance #patientsafety, help prevent drug diversion, and give clinicians more time for patient care.https://ow.ly/Q5sY50RAizt Pharmaceutical Commerce Magazine Fresenius Kabi #GS1Standards

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs